DMAA (from Geranium Extract)
Introduction to DMAA Biochemistry
DMAA, chemically known as 1,3-dimethylamylamine or methylhexanamine, is a simple aliphatic amine. Structurally, it shares similarities with both amphetamines and endogenous catecholamines, which dictates its primary mechanism of action within the human body. Originally synthesized and patented in the 1940s as a pharmaceutical nasal decongestant, its primary pharmacological utility was derived from its ability to induce localized vasoconstriction in the nasal mucosa. However, when ingested orally in systemic doses, particularly in the context of sports nutrition and weight loss supplements, its biochemical interactions trigger a cascade of potent and potentially dangerous physiological responses.
Indirect Sympathomimetic Action
DMAA functions primarily as an indirect-acting sympathomimetic agent. Unlike direct agonists that bind directly to adrenergic receptors (such as epinephrine or albuterol), DMAA exerts its effects by modulating the release and reuptake of endogenous neurotransmitters, specifically norepinephrine (noradrenaline) and, to a lesser extent, dopamine. Upon crossing the blood-brain barrier—a process facilitated by its lipophilic aliphatic structure—DMAA enters the presynaptic nerve terminals. Once inside, it interacts with the vesicular monoamine transporter (VMAT), displacing norepinephrine from synaptic vesicles into the cytosol. This displacement causes a reversal of the norepinephrine transporter (NET), effectively pumping massive amounts of norepinephrine into the synaptic cleft.
Alpha-Adrenergic Receptor Activation and Vasoconstriction
The flood of norepinephrine into the synaptic cleft leads to widespread activation of adrenergic receptors throughout the body. The most critical and dangerous physiological consequence of DMAA ingestion is the intense activation of alpha-1 adrenergic receptors located on the smooth muscle cells of peripheral blood vessels. When norepinephrine binds to these alpha-1 receptors, it triggers a Gq-protein coupled intracellular signaling cascade. This cascade activates phospholipase C (PLC), leading to the production of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates the release of calcium ions from the sarcoplasmic reticulum, resulting in robust and sustained smooth muscle contraction.
This widespread vasoconstriction drastically reduces the diameter of blood vessels and arteries, leading to a sharp and sudden increase in peripheral vascular resistance. Consequently, the user experiences a significant spike in both systolic and diastolic blood pressure. The FDA explicitly warns that this narrowing of blood vessels is a primary mechanism by which DMAA induces severe cardiovascular events, including shortness of breath, tightening in the chest, and acute myocardial infarction (heart attack).
Cardiac Electrophysiology and Arrhythmogenesis
In addition to peripheral vasoconstriction, the systemic release of norepinephrine also stimulates beta-1 adrenergic receptors located in the myocardium (heart muscle) and the sinoatrial (SA) node. Beta-1 activation operates via a Gs-protein coupled pathway, increasing intracellular cyclic AMP (cAMP) and activating protein kinase A (PKA). This results in positive chronotropic (increased heart rate), inotropic (increased contractility), and dromotropic (increased conduction velocity) effects.
While this increases cardiac output, it forces the heart to work significantly harder against the massive afterload created by the alpha-1 mediated peripheral vasoconstriction. This mismatch between myocardial oxygen demand and oxygen supply can lead to ischemia. Furthermore, the intense beta-1 stimulation can disrupt normal cardiac electrophysiology, leading to irregular heartbeats or arrhythmias. The FDA and WebMD both highlight arrhythmias as a severe risk associated with DMAA consumption, which can degenerate into fatal ventricular fibrillation if left untreated.
Central Nervous System Stimulation and Neurological Effects
Within the central nervous system, the elevated levels of norepinephrine and dopamine in the prefrontal cortex and other brain regions result in the intense stimulant effects sought by users: heightened alertness, increased energy, and hyper-focus. However, this profound CNS stimulation comes with severe neurological risks. The FDA notes that DMAA use is linked to seizures and other adverse psychological conditions. The exact mechanism for DMAA-induced seizures is likely related to the extreme lowering of the seizure threshold caused by excessive catecholaminergic overstimulation and potential cerebral hypoxia secondary to severe cerebral vasoconstriction or stroke.
Metabolic Consequences: Lactic Acidosis
WebMD reports that DMAA use has been linked to lactic acidosis, a dangerous metabolic condition characterized by the buildup of lactate in the bloodstream and a drop in blood pH. The biochemical mechanism for this is likely multifactorial. First, the intense peripheral vasoconstriction reduces tissue perfusion, leading to localized cellular hypoxia. In the absence of adequate oxygen, cells are forced to rely on anaerobic glycolysis for ATP production, which generates lactate as a byproduct. Second, the massive surge in catecholamines hyper-stimulates cellular metabolism, increasing the rate of glycolysis beyond the capacity of the mitochondria to process pyruvate, further contributing to lactate accumulation. If the liver (which is also at risk of injury from DMAA, as noted by WebMD) cannot clear the lactate efficiently via the Cori cycle, systemic lactic acidosis ensues, which can be fatal.
The Myth of Natural Occurrence
For years, supplement manufacturers claimed that DMAA was a naturally occurring constituent of the geranium plant (Pelargonium graveolens) and its essential oils. This claim was used to bypass regulatory scrutiny by classifying DMAA as a natural dietary ingredient. However, rigorous analytical biochemistry has definitively debunked this myth. A landmark 2013 study conducted collaboratively by the NSF and the U.S. Army Research Institute of Environmental Medicine (USARIEM) utilized advanced chromatographic and mass spectrometric techniques to analyze authentic geranium plants and essential oils. The research conclusively demonstrated that 1,3-dimethylamylamine is entirely absent from Geranium or Pelargonium species. The DMAA found in dietary supplements, which ranged in concentration from 0.11% to 67.3%, is of purely synthetic origin, manufactured in laboratories. Therefore, it is an unapproved, illegal food additive rather than a natural dietary ingredient.
Does geranium have DMAA? +
Is geranium extract a stimulant? +
Does the DMAA test positive? +
Who should avoid DMAA? +
Is DMAA safe to take with caffeine? +
What plant is DMAA from? +
What are the side effects of DMHA? +
Why was DMAA banned by the FDA? +
Can DMAA cause a heart attack? +
Is DMAA legal in the US? +
How does DMAA affect blood pressure? +
Was DMAA ever used as a medication? +
What is the difference between 1,3-DMAA and 1,4-DMAA? +
Why do athletes use DMAA? +
Can DMAA cause liver damage? +
How do supplement companies hide DMAA on labels? +
Everything About DMAA (from Geranium Extract) Article
The Rise and Fall of DMAA in Sports Nutrition
For a brief period in the late 2000s and early 2010s, DMAA (1,3-dimethylamylamine) was the undisputed king of the pre-workout and fat-burner supplement market. Included in legendary, now-banned formulas like the original Jack3d and OxyElite Pro, DMAA was prized by bodybuilders and athletes for its ability to deliver unparalleled, euphoric energy and laser-like focus.
However, this intense stimulation came at a catastrophic cost. DMAA is not a natural dietary supplement; it is an amphetamine derivative and a potent synthetic drug. As adverse event reports began flooding in—ranging from severe panic attacks and arrhythmias to strokes, liver failure, and multiple deaths—regulatory bodies worldwide were forced to take unprecedented action. Today, DMAA is universally recognized as a dangerous, illegal substance, banned by the U.S. Food and Drug Administration (FDA), the World Anti-Doping Agency (WADA), and military bases globally.
The "Geranium Extract" Myth Debunked
To circumvent dietary supplement regulations, manufacturers engaged in a massive deception: they claimed that DMAA was a naturally occurring compound extracted from the rose geranium plant (Pelargonium graveolens). Supplement labels would frequently list ingredients like "geranium oil," "geranium stems," or "geranium extract," implying a safe, botanical origin.
This claim was entirely fabricated. A landmark 2013 collaborative study between the NSF and the U.S. Army Research Institute of Environmental Medicine (USARIEM) utilized advanced analytical chemistry to test authentic geranium plants and their essential oils. The results, published in the journal Drug Testing and Analysis, were definitive: 1,3-dimethylamylamine does not exist in nature. The DMAA found in dietary supplements—sometimes in massive concentrations up to 67.3%—was synthesized in laboratories. Because it is a synthetic chemical with no history of use in the food supply, the FDA classifies DMAA as an unsafe, unapproved food additive, making any supplement containing it adulterated and illegal.
Pharmacodynamics: How DMAA Affects the Brain and Body
Understanding why DMAA is so dangerous requires looking at its pharmacology. DMAA was originally developed in 1944 as a pharmaceutical nasal decongestant. It works as an indirect sympathomimetic, meaning it mimics the effects of the sympathetic nervous system—the body's "fight or flight" response.
When ingested, DMAA crosses the blood-brain barrier and forces the massive release of norepinephrine (noradrenaline). This flood of neurotransmitters binds to alpha-1 adrenergic receptors located on the smooth muscle of blood vessels, causing intense vasoconstriction (narrowing of the arteries).
While this mechanism effectively clears a stuffy nose when applied locally, taking it systemically via an oral supplement causes a violent spike in peripheral vascular resistance. The heart is suddenly forced to pump blood through a severely constricted vascular network, leading to rapid, dangerous spikes in both systolic and diastolic blood pressure.
Severe Cardiovascular Risks and Adverse Events
The FDA explicitly warns consumers that DMAA poses a severe health risk. The physiological strain caused by DMAA's vasoconstrictive properties can lead to a cascade of life-threatening cardiovascular and neurological emergencies. Documented side effects include:
Myocardial Infarction (Heart Attack): The extreme workload placed on the heart, combined with restricted blood flow, can cause cardiac tissue death. Stroke: The sudden spike in blood pressure can cause blood vessels in the brain to rupture or become blocked. Arrhythmias: DMAA disrupts the heart's natural electrical rhythm, leading to irregular heartbeats that can degenerate into fatal ventricular fibrillation. Lactic Acidosis: WebMD notes that DMAA use has been linked to this dangerous metabolic condition, where lactate builds up in the bloodstream faster than it can be cleared, causing blood pH to drop to toxic levels. Liver Injury: Hepatotoxicity and acute liver failure have been reported in users consuming DMAA-based fat burners. Seizures: The intense central nervous system stimulation can lower the seizure threshold, leading to neurological emergencies.
These risks are exponentially magnified when DMAA is combined with other stimulants, such as caffeine, which is standard practice in pre-workout formulations.
Regulatory Actions and Legal Status
The FDA does not have any information to demonstrate that consuming DMAA is safe. Starting in 2012, the agency launched a massive crackdown. They issued warning letters to companies notifying them that marketing DMAA-containing products violates federal law.
When some companies refused to comply, the FDA escalated their actions. In 2013, the FDA administratively detained and seized products like OxyElite Pro and Jack3d, destroying millions of dollars worth of inventory. Federal courts have consistently upheld the FDA's stance, ruling in 2017 and affirming in 2019 that DMAA is not a dietary ingredient and is not generally recognized as safe (GRAS).
Furthermore, the World Anti-Doping Agency (WADA) added DMAA to its prohibited substances list in 2010. Any competitive athlete who tests positive for DMAA faces immediate suspension and sanctions. The U.S. military also removed all DMAA products from base exchanges following the tragic deaths of several service members who collapsed during physical training after consuming DMAA supplements.
1,3-DMAA vs. 1,4-DMAA: Is There a Difference?
As regulatory pressure mounted against 1,3-DMAA, some unscrupulous manufacturers attempted to pivot to a structural isomer known as 1,4-DMAA (1,4-Dimethylamylamine or 1,4-Dimethylpentylamine).
WebMD and the FDA are clear: 1,4-DMAA carries the exact same legal and health risks as its predecessor. It is also a synthetic stimulant, it is also falsely claimed to be sourced from geranium, and it is also illegal. The physiological effects—rapid heartbeat, increased blood pressure, and risk of heart attack or stroke—are identical. Consumers should avoid any product listing 1,4-DMAA just as strictly as 1,3-DMAA.
Conclusion: Avoid at All Costs
There is no safe dose of DMAA. It is an illegal, synthetic drug masquerading as a dietary supplement. If you see a product claiming to contain DMAA, methylhexanamine, or "geranium extract" intended to provide a stimulant effect, you are looking at an adulterated product that poses a direct threat to your life. Always look for supplements that are third-party tested by organizations like NSF, which verify that products are free from dangerous, banned contaminants like DMAA.